ROR/NR1F Agonists

Nuclear hormone receptors are key targets for drug development as many are implicated in diabetes and other endocrine disorders as well as cancer. These molecules are ligand-dependent transcription factors that regulate gene expression in response to a wide range of developmental, physiological, and environmental cues. R&D Systems offers the most...